SRNE (OTC)
SORRENTO THERAPEUTICS INC
$0.001100
+0.000400 (+57.14%)
Prev close: $0.000700
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Henry H. Ji, PhD
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $0.61M
- Employees
- —
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $64.27M |
| Benefits Costs and Expenses | $635.45M |
| Costs And Expenses | $526.92M |
| Operating Expenses | $526.92M |
| Depreciation and Amortization | $13.93M |
| Other Operating Expenses | $512.99M |
| Operating Income/Loss | -$462.65M |
| Income/Loss Before Equity Method Investments | -$552.86M |
| Income/Loss From Continuing Operations After Tax | -$580.96M |
| Income/Loss From Continuing Operations Before Tax | -$571.28M |
| Income/Loss From Equity Method Investments | -$18.74M |
| Income Tax Expense/Benefit | $9.31M |
| Interest Expense, Operating | $6.81M |
| Net Income/Loss | -$580.90M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$32.81M |
| Net Income/Loss Attributable To Parent | -$548.10M |
| Net Income/Loss Available To Common Stockholders, Basic | -$563.11M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.12 |
| Diluted Earnings Per Share | -$1.12 |
| Basic Average Shares | 1,020,567,000 |
| Diluted Average Shares | 1,020,567,000 |
| Assets | $456.69M |
| Current Assets | $133.11M |
| Inventory | $9.65M |
| Prepaid Expenses | $5.22M |
| Other Current Assets | $118.24M |
| Noncurrent Assets | $323.58M |
| Fixed Assets | $53.24M |
| Intangible Assets | $122.28M |
| Other Non-current Assets | $148.06M |
| Liabilities | $654.65M |
| Current Liabilities | $264.95M |
| Accounts Payable | $18.55M |
| Wages | $6.96M |
| Other Current Liabilities | $239.43M |
| Noncurrent Liabilities | $389.70M |
| Equity | -$197.96M |
| Equity Attributable To Noncontrolling Interest | $7.16M |
| Equity Attributable To Parent | -$205.11M |
| Liabilities And Equity | $456.69M |
| Net Cash Flow From Operating Activities | -$234.63M |
| Net Cash Flow From Operating Activities, Continuing | -$234.63M |
| Net Cash Flow From Investing Activities | -$11.58M |
| Net Cash Flow From Investing Activities, Continuing | -$11.58M |
| Net Cash Flow From Financing Activities | $246.59M |
| Net Cash Flow From Financing Activities, Continuing | $246.59M |
| Exchange Gains/Losses | -$974.00K |
| Net Cash Flow | -$596.00K |
| Net Cash Flow, Continuing | $378.00K |
| Comprehensive Income/Loss | -$579.50M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | -$32.81M |
| Comprehensive Income/Loss Attributable To Parent | -$546.69M |
| Other Comprehensive Income/Loss | $1.08M |
| Other Comprehensive Income/Loss Attributable To Parent | $1.40M |